investorscraft@gmail.com

Medpace Holdings, Inc. (MEDP)

Previous Close
$321.50
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)163.16-49
Intrinsic value (DCF)516.7061
Graham-Dodd Method70.58-78
Graham Formula253.65-21

Company Information

5375 Medpace Way
Cincinnati, OH 45227
United States
Phone: 513 579 9911
Industry: Medical - Diagnostics & Research
Sector: Healthcare
CEO: Dr. August James Troendle M.D.
Full Time Employees: 5900

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

HomeMenuAccount